Regencell Bioscience Holdings Limited (NASDAQ: RGC)
$5.9000
+0.0100 ( +3.33% ) 21.5K
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Market Data
Open
$5.9000
Previous close
$5.8900
Volume
21.5K
Market cap
$79.38M
Day range
$5.5100 - $6.0670
52 week range
$3.0300 - $32.4400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 20-f | Annual reports | 72 | Oct 25, 2024 |
| 6-k | Form 6-K | 2 | Jun 20, 2024 |
| 6-k | Form 6-K | 2 | Jan 02, 2024 |
| 6-k | Form 6-K | 2 | Dec 15, 2023 |